SEC Form 4 · accession 0001019687-15-000790
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell Joseph Harrison
Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 3, 2015 · 6:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2,F1 | $0.86 | Mar 2, 2015 | A | 8,296 | A | Mar 2, 2015 | Mar 2, 2025 | Common Stock | 8,296 | 70,022 | D |
Explanation of responses
- F1The options vest immediately, on the date such options were granted.
- F2The option was granted by the Issuer pursuant to the Non-Employee Director Compensation Plan.